Skip to main content
Clinical Trials/CTRI/2022/08/044536
CTRI/2022/08/044536
Not yet recruiting
未知

Evaluation of cardiovascular disease risk in type 2 diabetes mellitus patients using framingham risk score, qrisk3, interheart risk scores and their correlation with lipoprotein (a) level.

Dr Ramesh Kumar Chandak0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
Dr Ramesh Kumar Chandak
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Dr Ramesh Kumar Chandak

Eligibility Criteria

Inclusion Criteria

  • With or Without Microvascular Complications of type 2 DM

Exclusion Criteria

  • 1Previous history of CVD.
  • 2Patients with macrovascular complications of diabetes.
  • 3Terminally ill.
  • 4Severe liver and renal insufficiency.
  • 7Thyroid dysfunctions.
  • 8Severe mental illness.
  • 9Pregnancy.
  • 10Peripheral artery disease.
  • 11Hemolytic disease.
  • 12Fever \& goiter.

Outcomes

Primary Outcomes

Not specified

Similar Trials